Anti-Inhibitor Coagulant Complex (Autoplex, Feiba Nf, Feiba Vh)
Anti-Inhibitor Coagulant Complex is an FDA-licensed reference biologic from Takeda Pharmaceuticals U.S.A., Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2000
Reference approved
Reference product
Autoplex, Feiba Nf, Feiba Vh Anti-Inhibitor Coagulant Complex
Takeda Pharmaceuticals U.S.A., Inc.
- Approved
- Jul 31, 2000
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Anti-Inhibitor Coagulant Complex, in chronological order.
Reference approval
Approval date of the reference Anti-Inhibitor Coagulant Complex product.
26 yr 3 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
5 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for Anti-Inhibitor Coagulant Complex (Autoplex, Feiba Nf, Feiba Vh)?
No 351(k) biosimilars or interchangeable biosimilars referencing Anti-Inhibitor Coagulant Complex are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.